Back

Effect of SGLT2 inhibitors in the management of moroccan patients with heart failure with reduced ejection fraction

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Poster session 1 - Managing cardiovascular risk: pharmacological and digital tools Pharmacotherapy Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Professor Najat Mouine

Military Hospital Mohammed V, Rabat (Morocco)

5 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor P. Poggio (Milan, IT)
Abstract Slides
Presentation thumbnail
Professor A. Abreu (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Mr D. Tsounis (Nea Makri, GR)
Abstract
Presentation thumbnail
Doctor J. Torres Marques (Palma de Mallorca, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Managing cardiovascular risk: pharmacological and digital tools

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2i in heart failure with reduced ejection fraction: benefits in real life?
22 May 2023
thumbnail
Congress Presentation
Exercise-Based Cardiac Rehabilitation in post myocardial infarction patients with mid-range ejection fraction
1 September 2019
thumbnail
Congress Session
How to treat a patient with heart failure and a left ventricular ejection fraction (LVEF) > 40%
27 August 2022
thumbnail
Congress Presentation
Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis
1 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources